us.discovericl.com Open in urlscan Pro
159.255.219.186  Public Scan

Form analysis
2 forms found in the DOM

<form class="relative m-form-search"><input name="q" aria-label="Enter Your ZIP Code" autocomplete="off"
    class="w-full font-bold placeholder-current uppercase transition-all duration-300 bg-transparent border-2 border-current pie-14 m-form-search__input text-button" placeholder="Enter Your ZIP Code" type="text"><button
    class="absolute top-0 inline-end-0 inline-flex items-center justify-center h-full w-14 m-form-search__button" type="submit"><span class="a-svg stroke-current w-8 h-8"><svg viewBox="0 0 32 32" fill="none" xmlns="http://www.w3.org/2000/svg">
        <path d="M26.667 26.667 20 20M13.867 22.4a8.533 8.533 0 1 0 0-17.067 8.533 8.533 0 0 0 0 17.067Z" stroke="#10A8BA" stroke-width="2" stroke-miterlimit="10" stroke-linecap="round" stroke-linejoin="round"></path>
      </svg></span></button></form>

<form class="relative m-form-search"><input name="q" aria-label="Enter Your email to Stay updated" autocomplete="off"
    class="w-full font-bold placeholder-current uppercase transition-all duration-300 bg-transparent border-2 border-current pie-14 m-form-search__input text-button" placeholder="Enter Your email to Stay updated" type="email"><button
    class="absolute top-0 inline-end-0 inline-flex items-center justify-center h-full w-14 m-form-search__button" type="submit"><span class="a-svg w-8 h-8 duration-200 ease-out fill-current hover:text-primary-teal animate-opacity"><svg
        viewBox="0 0 33 32" fill="none" xmlns="http://www.w3.org/2000/svg">
        <path d="M25.667 6.667H7c-.8 0-1.333.533-1.333 1.333v1.867l10.667 6L27 10V8c0-.8-.533-1.333-1.333-1.333Z" fill="#10A8BA"></path>
        <path d="m15.667 18.533-10-5.6V24c0 .8.533 1.333 1.333 1.333h18.667c.8 0 1.333-.533 1.333-1.333V12.933l-10 5.6c-.373.187-.96.187-1.333 0Z" fill="#10A8BA"></path>
      </svg></span></button></form>

Text Content

简体中文

English

Safety Information

US
 * What Is EVO?
 * EVO Benefits
    * Sharp, Clear Vision Day and Night
    * Tired of Dry Eyes?
    * Harmony w / Natural Eye

 * Procedure
 * Testimonials
 * FAQ
 * Do I Qualify?
 * Find a Doctor
 * 

    * Back
    * Sharp, Clear Vision Day and Night
    * Tired of Dry Eyes?
    * Harmony w / Natural Eye

 * Do I Qualify?
 * Find a Doctor
 * What Is EVO?
 * EVO Benefits
 * Procedure
 * Testimonials
 * FAQ
 * EVO ICL Blog

 * Contact
 * Safety Information
 * International Sites

 * 
 * 
 * 


UPGRADE YOUR VISION

Kevin and Joe Jonas chose the EVO ICL lens (EVO) procedure to help them get rid
of the hassles of their contacts and glasses.

Read Kevin and Joe's Story
Scroll



SEE LIFE IN FULL DETAIL

Explore the EVO ICL Implantable Collamer® Lenses to unlock visual freedom and a
life rich with new experiences.

Do I Qualify?


TIRED OF DEALING WITH DRY EYE?

EVO ICL does not cause contact lens induced dry eye nor dry eye syndrome, which
could mean a more comfortable journey as you achieve visual freedom.

About No Dry Eye Syndrome


ENVISION A LIFE WITHOUT HESITATION

From hitting the gym to hitting the waves, EVO ICL means you’re always ready to
live life to the fullest.

See if EVO ICL is right for you.

Do I Qualify?


EXPERIENCE THE MORE NATURAL CHOICE

EVO ICL is vision correction that’s in harmony with your natural eye, keeping it
completely intact.

Harmony With Your Natural Eye


SEE CLEARLY DAY AND NIGHT

Whether on an adventure or simply reading about one, EVO ICL helps you see
clearly – day and night.

More About Improved Night Vision


YOUR FUTURE’S BRIGHT, AND PROTECTED

EVO ICL has a unique barrier of UV protection.

Check to see if you're a candidate.

Do I Qualify?


2 MILLION+

Lenses Distributed


99.4%

Of patients surveyed would have the procedure again ¹

Over 2 million ICL lenses have been distributed. Find a doctor now to schedule a
consultation.


NEXT UP


THE VISUAL FREEDOM YOU DESERVE


READY TO DISCOVER VISUAL FREEDOM WITH EVO ICL? FIND A DOCTOR TODAY


Use my current location


IMPORTANT SAFETY INFORMATION

The EVO Visian ICL Lens is intended for the correction of moderate to high
nearsightedness. EVO Visian ICL and EVO Visian TICL surgery is intended to
safely and effectively correct nearsightedness between -3.0 D to -15.0 D, the
reduction in nearsightedness up to -20.0 D and treatment of astigmatism from 1.0
D to 4.0 D. If you have nearsightedness within these ranges, EVO Visian ICL
surgery may improve your distance vision without eyeglasses or contact lenses.
Because the EVO Visian ICL corrects for distance vision, it does not eliminate
the need for reading glasses, you may require them at some point, even if you
have never worn them before.

Implantation of the EVO Visian ICL is a surgical procedure, and as such, carries
potentially serious risks. Please discuss the risks with your eye care
professional. Complications, although rare, may include need for additional
surgical procedures, inflammation, loss of cells from the back surface of the
cornea, increase in eye pressure, and cataracts.

You should NOT have EVO Visian ICL surgery if:

 * Your doctor determines that the shape of your eye is not an appropriate fit
   for the EVO Visian ICL
 * You are pregnant or nursing
 * You have moderate to severe damage to the optic nerve caused by increased
   pressure (glaucoma)
 * You do not meet the minimum endothelial cell density for your age at the time
   of implantation as determined by your eye doctor
 * Your vision is not stable as determined by your eye doctor
   

Before considering EVO Visian ICL surgery you should have a complete eye
examination and talk with your eye care professional about EVO Visian ICL
surgery, especially the potential benefits, risks, and complications. You should
discuss the time needed for healing after surgery. For additional information
with potential benefits, risks and complications please visit DiscoverICL.com.


References


SELECT YOUR REGION


EUROPE

AustriaBelgium - DutchBelgium -
FrenchFranceGermanyItalyNetherlandsNorwayPortugalSloveniaSpainSwedenSwitzerlandUK
& Ireland


NORTH AMERICA

CanadaCanada - FrenchMexicoUnited StatesUnited States - 中文


LATIN AMERICA

EnglishSpanishPortuguese


NORTH AFRICA

ArabicFrench


MIDDLE EAST

Middle East عربىMiddle East - فارسيMiddle East - English


ASIA PACIFIC

AustraliaChina - 中国IndiaJapan - 日本New ZealandS. Korea - 대한민국South East Asia


REFERENCES

¹Patient Survey, STAAR Surgical ICL Data Registry, 2018


²Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and
laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec;
25(10):1139-46.

³Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements
as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American
Society of Cataract and Refractive Surgery (ASCRS) 2012.

⁴Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk
factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.

5aLee, Jae Bum et al. Comparison of tear secretion and tear film instability
after photorefractive keratectomy and laser in situ keratomileusis. Journal of
Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.

5bParkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in
United States military warfighters: A retrospective analysis of early clinical
outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.

⁶Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+
Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of
Vision and Life, Am J Ophthalmol 2021;226:117-125.

⁷Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month
results from the United States Food and Drug Administration clinical trial.
Clinical Ophthalmology. 2022;16:1541-53.

⁸Parkhurst GD. A prospective comparison of phakic collamer lenses and
wavefront-optimized laser-assisted in situ keratomileusis for correction of
myopia. Clin Ophthalmol. 2016;10:1209-1215.

⁹Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and
patient satisfaction between 3 modalities for the correction of low to moderate
myopic astigmatism. Clin Ophthalmol. 2017;11:1253-1263.

*American Refractive Surgery Council

 * Testimonials
 * Safety Information
 * EVO ICL Blog
 * Contact

 * 
 * 
 * 

STAY UPDATED ON EVO VISIAN ICL

STAAR Surgical, as the data controller, would like to contact you periodically
to provide information regarding our products, services, events and content that
may be of interest to you. By providing your email address, you agree to receive
marketing or market research communications from STAAR Surgical via email. If
you wish to stop receiving marketing or market research communications from
STAAR Surgical you can unsubscribe via the link at the bottom of the relevant
marketing email at any time. For further information on how we use your personal
data please refer to our online Privacy Statement.

© 2023 Staar Surgical. All Rights Reserved.

 * Privacy Policy
 * Terms of use
 * International Sites